Analysis of the Prognosis and Related Factors for Patients With Stage IV Gestational Trophoblastic Neoplasia
Authors:
Open Access
- 1 March 2014
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 24 (3) , 594-599
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Role of Surgery in the Management of Gestational Trophoblastic NeoplasiaObstetrical & Gynecological Survey, 2013
- Role of Adjuvant Hysterectomy in Management of High-Risk Gestational Trophoblastic NeoplasiaInternational Journal of Gynecological Cancer, 2012
- Etoposide, cisplatin–etoposide, methotrexate, actinomycin‐D as primary treatment for management of very‐high‐risk gestational trophoblastic neoplasiaInternational Journal of Gynecology & Obstetrics, 2011
- Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasiaAnnals of Oncology, 2011
- Surgical Resection in the Management of Pulmonary Metastatic Disease of Gestational Trophoblastic NeoplasiaInternational Journal of Gynecological Cancer, 2009
- Gestational trophoblastic neoplasia: an updateCurrent Oncology Reports, 2008
- The practicability of FIGO 2000 staging for gestational trophoblastic neoplasiaInternational Journal of Gynecological Cancer, 2004
- Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy☆Gynecologic Oncology, 2003
- Sequential use of methotrexate and actinomycin D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in womenAmerican Journal of Obstetrics and Gynecology, 1965
- Five years' experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in womenAmerican Journal of Obstetrics and Gynecology, 1961